{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T03:42:23Z","timestamp":1777606943693,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004607","name":"Guangxi Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004607","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.bioorg.2024.107815","type":"journal-article","created":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T08:15:19Z","timestamp":1726042519000},"page":"107815","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Pomalidomide sensitizes lung cancer cells to TRAIL\/CDDP-induced apoptosis via directly targeting electron transfer flavoprotein alpha subunit"],"prefix":"10.1016","volume":"153","author":[{"given":"Liangping","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zetian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongkun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuesong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pingping","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenqing","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yufei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shulan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guohai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.bioorg.2024.107815_b0005","doi-asserted-by":"crossref","first-page":"6234","DOI":"10.1039\/D2CS00116K","article-title":"Discovery of CRBN as a target of thalidomide: a breakthrough for progress in the development of protein degraders","volume":"51","author":"Yamamoto","year":"2022","journal-title":"Chem. Soc. Rev."},{"issue":"11","key":"10.1016\/j.bioorg.2024.107815_b0010","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/s41589-020-0645-3","article-title":"ARID2 is a pomalidomide-dependent CRL4 (CRBN) substrate in multiple myeloma cells","volume":"16","author":"Yamamoto","year":"2020","journal-title":"Nat. Chem. Biol."},{"issue":"3","key":"10.1016\/j.bioorg.2024.107815_b0015","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.lungcan.2007.08.032","article-title":"Phase II trial of thalidomide with chemotherapy and as maintenance therapy for patients with poor prognosis small-cell lung cancer","volume":"59","author":"Lee","year":"2008","journal-title":"Lung Cancer"},{"issue":"21","key":"10.1016\/j.bioorg.2024.107815_b0020","first-page":"2176","article-title":"Gefitinib combined with thalidomide as the first line treatment against advanced pulmonary adenocarcinoma with EGFR mutation","volume":"37","author":"Chen","year":"2017","journal-title":"China J. Hosp. Pharm."},{"issue":"4","key":"10.1016\/j.bioorg.2024.107815_b0025","first-page":"298","article-title":"Randomized study of thalidomide combined with vinorelbine and cisplatin chemotherapy for the treatment of advanced non-small cell lung cancer","volume":"31","author":"Gu","year":"2009","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"issue":"9","key":"10.1016\/j.bioorg.2024.107815_b0030","doi-asserted-by":"crossref","first-page":"932","DOI":"10.3109\/07357900801944856","article-title":"Phase II trial of thalidomide, irinotecan and gemcitabine in chemonaive patients with advanced non-small cell lung cancer","volume":"27","author":"Jazieh","year":"2009","journal-title":"Cancer Invest."},{"issue":"16","key":"10.1016\/j.bioorg.2024.107815_b0035","doi-asserted-by":"crossref","first-page":"5984","DOI":"10.1158\/1078-0432.CCR-05-0577","article-title":"Immunomodulatory drug CC-5013 or CC-4047 and rituximab enhance antitumor activity in a severe combined immunodeficient mouse lymphoma model","volume":"11","author":"Hernandez-Ilizaliturri","year":"2005","journal-title":"Clin. Cancer Res."},{"issue":"5971","key":"10.1016\/j.bioorg.2024.107815_b0040","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1126\/science.1177319","article-title":"Identification of a primary target of thalidomide teratogenicity","volume":"327","author":"Ito","year":"2010","journal-title":"Science"},{"issue":"7933","key":"10.1016\/j.bioorg.2024.107815_b0045","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/s41586-022-05333-5","article-title":"The E3 ligase adapter cereblon targets the C-terminal cyclic imide degron","volume":"610","author":"Ichikawa","year":"2022","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.bioorg.2024.107815_b0050","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/s41375-018-0036-x","article-title":"Targeting MYC in multiple myeloma","volume":"32","author":"Jovanovi\u0107","year":"2018","journal-title":"Leukemia"},{"issue":"6168","key":"10.1016\/j.bioorg.2024.107815_b0055","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1126\/science.1244851","article-title":"Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells","volume":"343","author":"Kr\u00f6nke","year":"2014","journal-title":"Science"},{"issue":"6168","key":"10.1016\/j.bioorg.2024.107815_b0060","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1126\/science.1244917","article-title":"The myeloma drug lenalidomide promotes the cereblon-dependent destruction of Ikaros proteins","volume":"343","author":"Lu","year":"2014","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.bioorg.2024.107815_b0065","doi-asserted-by":"crossref","first-page":"11395","DOI":"10.1096\/fj.201903060RR","article-title":"Role of cereblon in angiogenesis and in mediating the antiangiogenic activity of immunomodulatory drugs","volume":"34","author":"Beedie","year":"2020","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.bioorg.2024.107815_b0070","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/1878-0261.12157","article-title":"Dual inhibition of DNMTs and EZH2 can overcome both intrinsic and acquired resistance of myeloma cells to IMiDs in a cereblon-independent manner","volume":"12","author":"Dimopoulos","year":"2018","journal-title":"Mol. Oncol."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107815_b0075","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41375-020-0809-x","article-title":"Immunomodulatory drugs activate NK cells via both Zap-70 and cereblon-dependent pathways","volume":"35","author":"Hideshima","year":"2021","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.bioorg.2024.107815_b0080","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1182\/blood-2016-09-738500","article-title":"p53-related protein kinase confers poor prognosis and represents a novel therapeutic target in multiple myeloma","volume":"129","author":"Hideshima","year":"2017","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.bioorg.2024.107815_b0085","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1073\/pnas.1910765117","article-title":"Hepatic neddylation targets and stabilizes electron transfer flavoproteins to facilitate fatty acid beta-oxidation","volume":"117","author":"Zhang","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"15","key":"10.1016\/j.bioorg.2024.107815_b0090","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1021\/bi00336a016","article-title":"Electron-transfer flavoprotein-ubiquinone oxidoreductase from pig liver purification and molecular, redox, and catalytic properties","volume":"24","author":"Beckmann","year":"1985","journal-title":"Biochemistry"},{"issue":"44","key":"10.1016\/j.bioorg.2024.107815_b0095","doi-asserted-by":"crossref","first-page":"16212","DOI":"10.1073\/pnas.0604567103","article-title":"Structure of electron transfer flavoprotein-ubiquinone oxidoreductase and electron transfer to the mitochondrial ubiquinone pool","volume":"103","author":"Zhang","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bioorg.2024.107815_b0100","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1146\/annurev.physiol.64.082201.154705","article-title":"Fatty acid oxidation disorders","volume":"64","author":"Rinaldo","year":"2002","journal-title":"Annu. Rev. Physiol."},{"issue":"6","key":"10.1016\/j.bioorg.2024.107815_b0105","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/sj.cdd.4400262","article-title":"Apoptosis and necrosis intracellular ATP level as a determinant for cell death modes","volume":"4","author":"Tsujimoto","year":"1997","journal-title":"Cell Death Differ."},{"issue":"11","key":"10.1016\/j.bioorg.2024.107815_b0110","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/sj.cdd.4401661","article-title":"Cells die with increased cytosolic ATP during apoptosis: a bioluminescence study with intracellular luciferase","volume":"12","author":"Zamaraeva","year":"2005","journal-title":"Cell Death Differ."},{"issue":"10","key":"10.1016\/j.bioorg.2024.107815_b0115","first-page":"1835","article-title":"Intracellular ATP levels determine cell death fate by apoptosis or necrosis","volume":"57","author":"Eguchi","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2024.107815_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114455","article-title":"Design and synthesis of proteolysis targeting chimeras (PROTACs) as an EGFR degrader based on CO-1686","volume":"238","author":"Li","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"7512","key":"10.1016\/j.bioorg.2024.107815_b0125","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nature13527","article-title":"Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide","volume":"512","author":"Fischer","year":"2014","journal-title":"Nature"},{"issue":"6141","key":"10.1016\/j.bioorg.2024.107815_b0130","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1233606","article-title":"Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay","volume":"341","author":"Martinez Molina","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2024.107815_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2021.145407","article-title":"Electron transfer flavoprotein and its role in mitochondrial energy metabolism in health and disease","volume":"776","author":"Henriques","year":"2021","journal-title":"Gene"},{"issue":"6","key":"10.1016\/j.bioorg.2024.107815_b0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003563","article-title":"Multi-organ abnormalities and mTORC1 activation in zebrafish model of multiple acyl-CoA dehydrogenase deficiency","volume":"9","author":"Kim","year":"2013","journal-title":"PLoS Genet."},{"issue":"2","key":"10.1016\/j.bioorg.2024.107815_b0145","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1172\/JCI6926","article-title":"Safety and antitumor activity of recombinant soluble Apo2 ligand","volume":"104","author":"Ashkenazi","year":"1999","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.bioorg.2024.107815_b0150","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/5517","article-title":"Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo","volume":"5","author":"Walczak","year":"1999","journal-title":"Nat. Med."},{"issue":"10","key":"10.1016\/j.bioorg.2024.107815_b0155","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1158\/0008-5472.CAN-05-4386","article-title":"Apo2l\/Tumor necrosis factor-related apoptosis-inducing ligand prevents breast cancer-induced bone destruction in a mouse model","volume":"66","author":"Thai le","year":"2006","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.bioorg.2024.107815_b0160","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nrc2889","article-title":"IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer","volume":"10","author":"Gyrd-Hansen","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bioorg.2024.107815_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106558","article-title":"LY103, a pomalidomide derivative, alleviates taxol resistance in NSCLC via energy metabolism crosstalk and tumor microenvironment intervention","volume":"136","author":"Wang","year":"2023","journal-title":"Bioorg. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2024.107815_b0170","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"20","key":"10.1016\/j.bioorg.2024.107815_b0175","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.1158\/1078-0432.CCR-17-0242","article-title":"Aspirin inhibits cancer metastasis and angiogenesis via targeting heparinase","volume":"23","author":"Dai","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"20","key":"10.1016\/j.bioorg.2024.107815_b0180","doi-asserted-by":"crossref","first-page":"8436","DOI":"10.1074\/jbc.M116.769380","article-title":"Metformin directly binds the alarmin HMGB1 and inhibits its proinflammatory activity","volume":"292","author":"Horiuchi","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"7899","key":"10.1016\/j.bioorg.2024.107815_b0185","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41586-022-04431-8","article-title":"Low-dose metformin targets the lysosomal AMPK pathway through PEN2","volume":"603","author":"Ma","year":"2022","journal-title":"Nature"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520682400720X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520682400720X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T02:22:16Z","timestamp":1738203736000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004520682400720X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":37,"alternative-id":["S004520682400720X"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107815","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pomalidomide sensitizes lung cancer cells to TRAIL\/CDDP-induced apoptosis via directly targeting electron transfer flavoprotein alpha subunit","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107815","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107815"}}